Restasis (Cyclosporine Ophthalmic Emulsion)

Restasis (Cyclosporine Ophthalmic Emulsion) used

Restasis (Cyclosporine Ophthalmic Emulsion) are used to increase natural tear production by the eye. Tear production is reduced due to inflammation associated with a chronic eye disease called keratoconjunctivitis sicca, more commonly known as dry eye disease, in which the eye does not produce sufficient tears to cover the cornea and protect the surface of the eye. This condition can be caused as a side effect of certain drugs, such as isotretinoin; as a symptom of certain diseases, such as rheumatoid arthritis; abnormal composition of tears causing them to evaporate rapidly; the aging process. Often there is no known cause (idiopathic). Chronic dry eyes results in inflammation and damage to the structures of the eye surface. Restasis Eye Drops 0.05% help prevent inflammation on the surface of the eye and this in turn helps increase natural tear production. Restasis Eye Drops 0.05% can also be used in conjunction with artificial tears.

Restasis (Cyclosporine Ophthalmic Emulsion) work

Restasis (Cyclosporine Ophthalmic Emulsion) contain cyclosporine, which is an immunosuppressive drug usually taken orally for suppressing the immune system and preventing rejection of organ transplants or for treatment of certain autoimmune diseases. When used for treating dry eye disease caused by reduced normal tear production, cyclosporine in Restasis Eye Drops 0.05% is thought to act as an immunomodulator by inhibiting the production of certain inflammatory chemicals called cytokines produced by lymphocytes at sites of inflammation. By damping down the effect of inflammatory cytokines in the eye, cyclosporine in Restasis Eye Drops 0.05% reduces local inflammation and helps the eyes resume normal tear production, which is important to protect and lubricate the eyes.